BioCryst Pharmaceuticals News

BioCryst Pharmaceuticals | DEFA14A: Others

Apr 25 16:27 ET

BioCryst Pharmaceuticals | DEF 14A: Definitive information statements

Apr 25 16:22 ET

BioCryst Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 27 17:14 ET

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones

Feb 26 07:10 ET

BioCryst Pharmaceuticals | 8-K: Current report

Jan 18 00:00 ET

BioCryst Pharmaceuticals | 8-K: Current report

Jan 8 00:00 ET

BioCryst Pharmaceuticals | 8-K: Current report

Dec 1, 2023 07:37 ET

BioCryst Pharmaceuticals | 8-K: Current report

Nov 30, 2023 09:04 ET

BioCryst Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 8, 2023 16:29 ET

BioCryst Pharmaceuticals | 8-K: Current report

Nov 3, 2023 12:16 ET

BioCryst Pharmaceuticals | 8-K: Current report

Nov 3, 2023 12:14 ET

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 2, 2023 07:05 ET

BioCryst Pharmaceuticals | 8-K: Current report

Oct 26, 2023 09:36 ET

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 3, 2023 07:04 ET

BioCryst Pharmaceuticals | 8-K: Current report

Jul 11, 2023 07:00 ET

BioCryst Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 30, 2023 07:33 ET

BioCryst Pharmaceuticals | 8-K: Current report

Jun 14, 2023 07:02 ET

BioCryst Pharmaceuticals | 8-K: BioCryst Reports First Quarter 2023 Financial Results and Provides Business Update

May 3, 2023 07:08 ET

BioCryst Pharmaceuticals | DEFA14A: Others

Apr 27, 2023 16:18 ET

BioCryst Pharmaceuticals | DEF 14A: Definitive proxy statements

Apr 27, 2023 16:17 ET